Russell Steven Jon's Form 4 filing
Beta Bionics, Inc. (BBNX) · filed Mar 16, 2026
- Accession no.
- 0002051384-26-000003
- Filed
- Mar 16, 2026
- Trade date
- Dec 2, 2025
- Filing delay
- 104 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $30.1K. It was filed 104 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Russell Steven JonCIK 0002051384 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | SSaleDisposed | −1,025 | $29.34 | −$30,073.5 | 178,071 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.